Concepedia

Mohamed Mahdi‐Rogers

MM

Statistics

Publications

10

Citations

1.3K

H-Index

10

Active since

2008

Affiliations

King's College London(Current)

Alexion Pharmaceuticals (United States)

National Hospital Organization Hanamaki Hospital

Stanford University

King's College Hospital NHS Foundation Trust

Mohamed Mahdi‐Rogers is an author at King's College London specializing in medicine, immunodeficiencies, and spinal cord injury.

Top concepts

Publications per year

2008–2023

10

Publications

10

Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study

James F. Howard, Kimiaki Utsugisawa, Michael Benatar et al. · The Lancet Neurology · 2017 · 745 citations

, , +3

Epidemiology of chronic inflammatory neuropathies in southeast <scp>E</scp>ngland

Mohamed Mahdi‐Rogers, R. A. C. Hughes · European Journal of Neurology · 2013 · 140 citations

Post-intervention Status in Patients With Refractory Myasthenia Gravis Treated With Eculizumab During REGAIN and Its Open-Label Extension

Renato Mantegazza, Gil I. Wolfe, Srikanth Muppidi et al. · Neurology · 2020 · 74 citations · Full text

Humoral and cellular immune responses to myelin protein peptides in chronic inflammatory demyelinating polyradiculoneuropathy

Lara Sanvito, Anna Makowska, Mohamed Mahdi‐Rogers et al. · Journal of Neurology Neurosurgery & Psychiatry · 2008 · 67 citations

Autologous peripheral blood stem cell transplantation for chronic acquired demyelinating neuropathy

Mohamed Mahdi‐Rogers, Majid Kazmi, Rosalie E. Ferner et al. · Journal of the Peripheral Nervous System · 2009 · 62 citations

, , +26

1–5 of 10